02 2010
Why fish oils work against diabetes
Researchers at the University of California, San Diego School of Medicine have identified the molecular mechanism that makes omega-3 fatty acids so effective in reducing chronic inflammation and insulin resistance.
The discovery could lead to development of a simple dietary remedy for many of the more than 23 million Americans suffering from diabetes and other conditions.
Writing in the advance online edition of the September 3 issue of the journal Cell, Jerrold Olefsky, MD, and colleagues identified a key receptor on macrophages abundantly found in obese body fat. Obesity and diabetes are closely correlated. The scientists say omega-3 fatty acids activate this macrophage receptor, resulting in broad anti-inflammatory effects and improved systemic insulin sensitivity.
22 2010
Neptune Technologies & Bioressources profits rise on krill oil success
Neptune Technologies & Bioressources has recorded continued profits in its first quarter, which the firm says is partly a result of a more widespread recognition of krill oil in the nutraceutical industry.
The Canadian firm reported a 45 percent increase in revenue for the three months ended May 31, 2010 compared to the same period last year. This boosted revenue to $4.2m for the period.
According to the company, the improved results were largely due to an investment in the firm’s manufacturing plant last year, which boosted production performance. However, the results also reflect an increased uptake of krill oil as a source of omega-3.
16 2010
Ocean Nutrition Canada (ONC) Adds New Omega-3 Microencapsulation Technology to Portfolio
Ocean Nutrition Canada (ONC) has added a new microencapsulation technology to its offerings buy purchasing a five-year license to the fish oil business and encapsulation technology of Austrian tech firm, GAT Food Essentials.
The undisclosed deal will see the Canadian fish oil leader take exclusive rights to GAT’s wowCAPS technology that has proved particularly suitable to dairy formulations, although ONC’s own PowderLoc encapsulation technology has had success there too.
ONC will also take control of GAT’s existing customers in the fish oil space, with there being potential for the two to work together on research and development and formulation.
26 2010
Enzymotec Krill Oil Product Gains Novel Food Approval in Europe
Enzymotec has announced that its leading product, Krill Oil +, has now obtained a Novel Food status in Europe for its Krill Product line , including the Pure Krill oil grade.
Recently the company announced the expansion of its product line into a greater variety of Krill-based combination products, including Krill-based variety of grades, Krill/PS combos and more.
“Enzymotec supports Krill sustainability and an eco-friendly supply chain aimed to maintain the conservation of marine living resources by sourcing its Krill biomass only from CCAMLR Member monitored vessels and facilities. Says Mrs. Neta Scheinman Enzymotec’s Director of QA. “We are inspecting and verifying that each Krill shipment is harvested within the limits of the zone and dates for which the specific fishing vessels had received it’s fishing license from CCALMR”, concludes Mrs. Scheinman.
26 2010
Novel process allows ‘highest quality’ omega-3 concentrations
Novel technology allows KD-Pharma, the fully-owned subsidiary of health care products company Bioseutica, to produce what it claims to be the market’s safest and highest quality omega-3 concentrations.
Specific combinations of omega-3 EPA/DHA at concentrations of up to 99 percent are produced by the process, known as kd pür, which was designed, developed and patented the company.
This is achieved by advanced super critical fluid technology conducted under mild temperatures below 45 Celsius and under CO2 atmospheric conditions to extract, refine and concentrate highly purified omega-3s from fish oil.
The process is also said to remove other undesired components from omega-3s such as omega-6, saturated fats, cholesterol and contaminants.
26 2010
Aker Biomarine’s Krill Fisheries Receives Marine Stewardship Council Certification
Aker BioMarine has today received confirmation that its krill fisheries will be certified by the Marine Stewardship Council (MSC), an independent, global, non-profit organization that works to promote the best choices in sustainable seafood.
In future purchases of Aker BioMarine’s Superba(tm) and Qrill(tm) products, consumers can be assured that their Omega-3 rich krill products are harvested in an environmentally sustainable way.
MSC’s fishery certification program contributes to the health of the world’s oceans by recognizing and rewarding sustainable fishing practices, influencing the choices people make when buying seafood and working with partners to transform the seafood market to a sustainable basis. The MSC certification is a visible demonstration of Aker BioMarine’s long term commitment to the environment.
14 2010
Carlson Laboratories Introduces Liquid CalaOmega from Calamari
Carlson Laboratories is proud to introduce Liquid CalaOmega, its newest Norwegian marine oil. Liquid CalaOmega from calamari oil is naturally rich in DHA. Although both DHA and EPA provide cardiovascular benefits, DHA is almost exclusively the only omega-3 fatty acid in our brains and eyes. Unlike most harvested marine life, the DHA levels in calamari oil are over twice as high as the EPA levels making it a preferred source. Liquid CalaOmega provides 800 mg of DHA and 400 mg of EPA per delicious lemon-flavored teaspoon.
14 2010
Aker BioMarine, Lipogen Come Together To Develop Phospholipids Formula
Aker BioMarine, an integrated biotechnology company positioned to create value from krill harvesting and processing and Lipogen, a producer of the functional cognitive ingredient phosphatidylserine (PS), have joined forces to develop a phospholipids formula for cognitive health.
Aker BioMarine and Lipogen said that the target formula is a matrix of Lipogen PS phosphatidylserine produced from Aker BioMarine’s pure Superba Krill Oil. Reportedly, Phosphatidylserine (PS) and omega-3 fatty acids are both key components of the brain’s cell membranes. The new ingredient could either be applied together with multivitamins or as a single ingredient targeting brain health.
07 2010
Maxomega-90 Omega-3 Launch: A ‘Blank Canvas’ For Formulators
Scottish firm Equateq announces today that high-end nutraceutical companies can now provide their customers with almost any ratio of EPA and DHA omega oil concentrates they want, with the launch of Maxomega-90, a range that exploits pharmaceutical sector separation methods to deliver omega-3 EPA and DHA in any 90% combination, Equateq announced today.
‘We say that Maxomega-90 is like a blank canvas, allowing companies to mix lipid actives in almost any combination they require,’ explained Equateq CEO Adam Kelliher. ‘This will enable companies to define their product rationale and give a more clear, and focused offering.’
Lipid specialist Equateq is unique in using industrial-scale chromatography to make lipid concentrates, in preference to the usual industry method of distillation. The Maxomega ™ process can separate all key lipids at up to 99% purity, but these super-high levels are mostly used by pharmaceutical companies and researchers. The Maxomega-90 range is geared for the nutritional sector, allowing delivery of EPA and DHA in any ratio, from 80/10 to 10/80, with each offering always having at least 90% total omega-3.
04 2010
Aker BioMarine signs first agreement for Superba Krill in Asia
Aker BioMarine has signed a distributor agreement with Compson Trade Co., Ltd for the Taiwanese market. This is the first step into the Asian market for Superba Krill and a milestone for Aker BioMarine.
“We are proud to work with a company like Compson Trade, and they have so far impressed us with their ambitions, dedication and high level of competence”, says Matts Johansen, Executive Vice President in Aker BioMarine.
Compson Trade was founded 15 years ago by Charlie Wu, and has through it’s focus on marketing, innovation, quality and customer service, grown to the leading supplier of dietary and pharmaceutical material in Taiwan. Aker BioMarine’s Superba Krill will with its new agreement have the best possible position to have success in Tawian.
RSS Feed 
Search
News Archive
Categories
Host
 |
Partners
 |
Sponsors
 |  |
Latest News
- Why fish oils work against diabetes
- Shellfish make great plastic; Research out of Australia
- Microalgae Industry Internet Directory Launched
- Maryland Aquarium Unveils New Conservation Center, Expanding Research
- Algenics Signs With Roquette For The Development Of An Innovative Microalgae Strain For High Value Industrial Uses
Recent Comments
- sitharth on Blue Bio Open Innovation (BBOI): Norway and Sweden Collaborate on Joint Marine Biotech Development
- Tweets that mention Aquapreneur - Sponge Genome Reveals Animal, Cancer Origins -- Topsy.com on Sponge Genome Reveals Animal, Cancer Origins
- Horris on GlycoMar files four patents advancing search for new drugs from the sea
- Tweets that mention Aquapreneur - Ongoing Project Aims to Recover Nutritional Value From Seafood and Brewing Waste -- Topsy.com on Ongoing Project Aims to Recover Nutritional Value From Seafood and Brewing Waste
- Twitted by Aquapreneur on “Jelloware” Drinking Cups from Seaweed Extract
Share Aquapreneur
